Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) EBT Margin: 2015-2025

Historic EBT Margin for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -1,688.82%.

  • AC Immune's EBT Margin fell 171041.00% to -1,688.82% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,642.83%, marking a year-over-year decrease of 149142.00%. This contributed to the annual value of -186.43% for FY2024, which is 17991.00% up from last year.
  • Latest data reveals that AC Immune reported EBT Margin of -1,688.82% as of Q3 2025, which was down 4.09% from -1,622.43% recorded in Q2 2025.
  • In the past 5 years, AC Immune's EBT Margin ranged from a high of 37,933.33% in Q2 2024 and a low of -397,950.00% during Q3 2021.
  • In the last 3 years, AC Immune's EBT Margin had a median value of -1,622.43% in 2025 and averaged 1,956.14%.
  • As far as peak fluctuations go, AC Immune's EBT Margin tumbled by 39,625,864bps in 2021, and later soared by 39,760,354bps in 2022.
  • Quarterly analysis of 5 years shows AC Immune's EBT Margin stood at -28,364.00% in 2021, then soared by 2,359,377bps to -4,770.23% in 2022, then soared by 333,296bps to -1,437.27% in 2023, then soared by 4,818bps to -1,389.09% in 2024, then tumbled by 171,041bps to -1,688.82% in 2025.
  • Its EBT Margin stands at -1,688.82% for Q3 2025, versus -1,622.43% for Q2 2025 and -1,922.12% for Q1 2025.